Literature DB >> 12860412

Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5.

Feng Liu1, Yuan Su, Baolin Li, Yan Zhou, John Ryder, Patricia Gonzalez-DeWhitt, Patrick C May, Binhui Ni.   

Abstract

The phosphorylation status of amyloid precursor protein (APP) at Thr668 is suggested to play a critical role in the proteolytic cleavage of APP, which generates either soluble APP(beta) (sAPP(beta)) and beta-amyloid peptide (Abeta), the major component of senile plaques in patient brains inflicted with Alzheimer's disease (AD), or soluble APP(alpha) (sAPP(alpha)) and a peptide smaller than Abeta. One of the protein kinases known to phosphorylate APP(Thr668) is cyclin-dependent kinase 5 (Cdk5). Cdk5 is activated by the association with its regulatory partner p35 or its truncated form, p25, which is elevated in AD brains. The comparative effects of p35 and p25 on APP(Thr668) phosphorylation and APP processing, however, have not been reported. In this study, we investigated APP(Thr668) phosphorylation and APP processing mediated by p35/Cdk5 and p25/Cdk5 in the human neuroblastoma cell line SH-SY5Y. Transient overexpression of p35 and p25 elicited distinct patterns of APP(Thr668) phosphorylation, specifically, p35 increasing the phosphorylation of both mature and immature APP, whereas p25 primarily elevated the phosphorylation of immature APP. Despite these differential effects on APP phosphorylation, both p35 and p25 overexpression enhanced the secretion of Abeta, sAPP(beta), as well as sAPP(alpha). These results confirm the involvement of Cdk5 in APP processing, and suggest that p35- and p25-mediated Cdk5 activities lead to discrete APP phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860412     DOI: 10.1016/s0014-5793(03)00714-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

Review 1.  Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions.

Authors:  Toshiharu Suzuki; Tadashi Nakaya
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

2.  Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells.

Authors:  Karla M Acevedo; Carlos M Opazo; David Norrish; Leesa M Challis; Qiao-Xin Li; Anthony R White; Ashley I Bush; James Camakaris
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

3.  p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.

Authors:  Rafael Andres Posada-Duque; Alejandro López-Tobón; Diego Piedrahita; Christian González-Billault; Gloria Patricia Cardona-Gomez
Journal:  J Neurochem       Date:  2015-05-04       Impact factor: 5.372

Review 4.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

5.  Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Authors:  Yun Ding; Aimin Qiao; Ziqing Wang; J Shawn Goodwin; Eun-Sook Lee; Michelle L Block; Matthew Allsbrook; Michael P McDonald; Guo-Huang Fan
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

6.  Cyclin-dependent kinase 5 is associated with risk for Alzheimer's disease in a Dutch population-based study.

Authors:  Alejandro Arias-Vásquez; Yurii S Aulchenko; Aaron Isaacs; Andy van Oosterhout; Kristels Sleegers; Albert Hofman; Christine van Broeckhoven; Ben A Oostra; Monique Breteler; Cornelia M van Duijn
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

Review 7.  The Role of Cdk5 in Alzheimer's Disease.

Authors:  Shu-Lei Liu; Chong Wang; Teng Jiang; Lan Tan; Ang Xing; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

8.  Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice.

Authors:  Gong-Ping Liu; Wei Wei; Xin Zhou; Hai-Rong Shi; Xing-Hua Liu; Gao-Shang Chai; Xiu-Qing Yao; Jia-Yu Zhang; Cai-Xia Peng; Juan Hu; Xia-Chun Li; Qun Wang; Jian-Zhi Wang
Journal:  Mol Ther       Date:  2013-08-07       Impact factor: 11.454

9.  Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease.

Authors:  Mirta Borin; Claudia Saraceno; Marcella Catania; Erika Lorenzetto; Valeria Pontelli; Anna Paterlini; Silvia Fostinelli; Anna Avesani; Giuseppe Di Fede; Gianluigi Zanusso; Luisa Benussi; Giuliano Binetti; Simone Zorzan; Roberta Ghidoni; Mario Buffelli; Silvia Bolognin
Journal:  Acta Neuropathol Commun       Date:  2018-07-13       Impact factor: 7.801

10.  Neuroprotective Sirtuin ratio reversed by ApoE4.

Authors:  Veena Theendakara; Alexander Patent; Clare A Peters Libeu; Brittany Philpot; Sonia Flores; Olivier Descamps; Karen S Poksay; Qiang Zhang; Gabriellee Cailing; Matthew Hart; Varghese John; Rammohan V Rao; Dale E Bredesen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.